Search - tctmd.com

Displaying 181 - 200 of 214

Sort: Relevancy | Date

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Optimization of Clinical Pathways for Treating Low Risk Patients with severe AS

CME

Optimization of Clinical Pathways for Treating Low Risk Patients with severe AS

CME

New Clinical Data on TAVR use and Intermediate Risk Patients

Managing the Growing Epidemic of HF: The Potential Role of Shunts

CME

Managing the Growing Epidemic of HF: The Potential Role of Shunts

Low-Risk Patients: The Changing Face of TAVR

CME

Low-Risk Patients: The Changing Face of TAVR

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty & Chordal Repair

CME

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair TCT 2022

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair

CME

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair

Latest Data on Left Main Stenting and its Implications

CME

Latest Data on Left Main Stenting and its Implications

Latest Data in Renal Denervation

CME

Latest Data in Renal Denervation

Latest Data & Therapy for Mitral & Tricuspid Valve Disease

CME

Latest Data & Therapy for Mitral & Tricuspid Valve Disease

Key Design Criteria For True Next Generation DES

CME

Key Design Criteria For True Next Generation DES

Partner Content

Key Design Criteria for True Next Generation DES

November 16, 2016

Improving TAVR Outcomes Duirng COVID-19: The Role Virtual Proctoring & CME

CME

Improving TAVR Outcomes During COVID-19: The Role Virtual Proctoring & CME

Defining Cost-Effectiveness and Quality of Life for TAVR

CME

Growing Indications for TAVR in 2018 and Beyond

Expanded TAVR Indications: Post TCT 2016

CME

Expanded TAVR Indications: Post TCT 2016

Evolving Thresholds for TAVR - Moving Down the Risk Spectrum

CME

Evolving Thresholds for TAVR - Moving Down the Risk Spectrum

Everyday Antiplatelet Decisions: Making the Right Choices

CME

Everyday Antiplatelet Decisions: Making the Right Choices

Evaluating the Heart Failure Patient with MR: Integrating Train Data Into Clinical Practice

CME

Evaluating the Heart Failure Patient with MR: Integrating Data Into Clinical Practice

Partner Content

Emerging Techniques in Mitral Valve Surgery

November 14, 2016

Emerging Indications for TAVR

CME

Emerging Indications for TAVR

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.